EV/EBITDA:
-9.67+0.15(+1.53%)Summary
- As of today, TNGX EV/EBITDA is -9.67, with a rise of +0.15 (+1.53%) during the most recent trading session on December 30, 2025.
- Over the past year, TNGX EV/EBITDA has dropped by -9.11 (-1626.79%).
- TNGX EV/EBITDA is now -712.03% below its all-time high of 1.58.
Performance
TNGX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TNGX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +1.5% | -1.5% | -1.4% |
| 1M1 Month | +22.7% | -22.7% | -20.9% |
| 3M3 Months | -27.4% | +27.4% | +2.7% |
| 6M6 Months | -255.5% | +147.5% | +68.5% |
| YTDYTD | -1139.7% | +835.8% | +179.3% |
| 1Y1 Year | -1626.8% | +1248.6% | +178.4% |
| 5Y5 Years | -6.4% | +332.3% | -24.0% |
TNGX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -9.45 | -2.3% | -12.51 | +22.7% |
| 3M | 3-Month | -6.05 | -59.8% | -12.51 | +22.7% |
| 6M | 6-Month | -2.72 | -255.5% | -12.51 | +22.7% |
| 1Y | 1-Year | 0.44 | -2297.7% | -12.51 | +22.7% |
| 3Y | 3-Year | 0.51 | -1996.1% | -12.51 | +22.7% |
| 5Y | 5-Year | 1.58 | -712.0% | -29.78 | +67.5% |
| All-Time | All-Time | 1.58 | -712.0% | -451K | +100.0% |
TNGX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -9.67(0.0%) |
| 2025 | -9.67(-1139.7%) |
| 2024 | -0.78(+88.0%) |
| Date | Value |
|---|---|
| 2023 | -6.48(-121.2%) |
| 2022 | -2.93(+65.1%) |
| 2021 | -8.39(-374.0%) |
| 2020 | -1.77 |
FAQ
- What is Tango Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Tango Therapeutics, Inc.?
- What is TNGX EV/EBITDA year-to-date change?
- What is Tango Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Tango Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of TNGX is -9.67
What is the all-time high EV/EBITDA for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high EV/EBITDA is 1.58
What is TNGX EV/EBITDA year-to-date change?
Tango Therapeutics, Inc. EV/EBITDA has changed by -8.89 (-1139.74%) since the beginning of the year
What is Tango Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, TNGX EV/EBITDA has changed by -9.11 (-1626.79%)